This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Apolipoprotein E (Apo-E)P02649A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia.
Clin Proteomics. 2014 Nov 19;11(1):40. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease.
PLoS One. 2014 Dec 3;9(12):e113651. doi: 10.1371/journal.pone.0113651. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Intraluminal proteome and peptidome of human urinary extracellular vesicles.
Proteomics Clin Appl. 2014 Dec 4. doi: 10.1002/prca.201400085.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Perturbations in the urinary exosome in transplant rejection.
Front Med (Lausanne). 2015 Jan 5;1:57. doi: 10.3389/fmed.2014.00057. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens.
Immunol Cell Biol. 2015 Mar 17. doi: 10.1038/icb.2015.33.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes released from breast cancer carcinomas stimulate cell movement.
PLoS One. 2015 Mar 23;10(3):e0117495. doi: 10.1371/journal.pone.0117495. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Identification of distinct circulating exosomes in Parkinson's disease.
Ann Clin Transl Neurol. 2015 Apr;2(4):353-61. doi: 10.1002/acn3.175. Epub 2015 Feb 6.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes released by keratinocytes modulate melanocyte pigmentation.
Nat Commun. 2015 Jun 24;6:7506. doi: 10.1038/ncomms8506.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Fragment)E9PEV4Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Fragment)E9PEV4Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis.
Int J Cardiol. 2015 Jun 14;197:333-347. doi: 10.1016/j.ijcard.2015.06.008.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance.
PLoS One. 2016 Feb 5;11(2):e0148407. doi: 10.1371/journal.pone.0148407. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Fibronectin-Containing Extracellular Vesicles Protect Melanocytes Against Ultraviolet Radiation-Induced Cytotoxicity.
J Invest Dermatol. 2016 Feb 5. pii: S0022-202X(16)00461-9. doi: 10.1016/j.jid.2015.08.001.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.
Oncotarget. 2016 Mar 30. doi: 10.18632/oncotarget.8483.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.
Oncotarget. 2016 Mar 30. doi: 10.18632/oncotarget.8483.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR.
Mol Neurodegener. 2016 May 23;11(1):41. doi: 10.1186/s13024-016-0108-1.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P18650Serum-derived exosomes from non-viremic animals previously exposed to the porcine respiratory and reproductive virus contain antigenic viral proteins.
Vet Res. 2016 May 31;47(1):59. doi: 10.1186/s13567-016-0345-x.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation.
J Transl Med. 2016 Jun 20;14(1):181. doi: 10.1186/s12967-016-0927-4.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Involvement of exosomes in lung inflammation associated with experimental acute pancreatitis.
J Pathol. 2016 Jul 22. doi: 10.1002/path.4771.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and their Microparticles.
J Proteome Res. 2016 Oct 19.
ENOG4111MYC347 / 0 / 347
< [2] [3] [4]